Aradigm corp (ARDM)
CashFlow / TTM
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-

0

-11,829

-

-

-18,766

-28,530

-32,938

0

0

0

-4,266

4,652

4,828

-9,132

-10,484

-21,564

-23,452

-10,540

-9,591

-8,226

-7,202

-7,689

-8,822

-9,309

0

0

0

Adjustments to reconcile net loss to cash used in operating activities:
Amortization and accretion of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29

-29

-26

-20

-14

0

0

0

-

-

-

-

Depreciation and amortization

133

130

124

118

116

119

120

121

0

0

0

313

310

323

333

351

370

371

376

383

391

399

405

419

445

0

0

0

Stock-based compensation expense

1,933

2,411

2,622

2,618

2,390

2,039

1,819

1,676

0

0

0

608

616

555

555

519

421

427

398

437

473

305

434

476

533

0

0

0

Amortization of convertible debt discount

1,869

1,857

1,847

1,788

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on assignment of royalty interests

-

-

-

-

-

-

-

-

-

-

-

-

5,823

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

3,041

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of convertible debt discount

-

-

-

-

-

-

-

-

-

-

-

-

19

46

71

93

94

85

75

67

59

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Cost of warrants and options for service

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Receivables

-245

-260

-136

33

323

10

-48

17

0

0

0

-2,182

966

-13,022

1,007

2,649

49

13,053

6

-7

5

7

-44

-26

-144

0

0

0

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid and other current assets

-218

1

-432

-648

-808

-1,711

-2,528

-2,597

0

0

0

161

-241

-299

755

1,086

1,342

1,064

8

-35

-55

-170

-230

55

-19

0

0

0

Other assets

-

-

0

-

-

-

0

-

-

-

-

2,851

2,840

2,815

2,778

-121

-121

-109

-98

-88

-107

-126

-121

369

413

0

0

0

Accounts payable

-767

-662

303

193

202

-93

-2,001

-1,078

0

0

0

480

2,087

860

3,181

1,362

289

168

604

21

134

228

-17

-7

-61

0

0

0

Accrued compensation

-984

-550

-199

752

846

572

566

176

0

0

0

111

621

267

665

194

14

308

5

-5

-11

-88

-424

-68

-132

0

0

0

Accrued clinical and cost of other studies, non-current

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

17

23

28

33

0

0

0

Deferred revenue - related party

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current deferred revenue - related party

-

-

0

-

-

-

-

-

-

-

-

-146

3,589

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,519

1,201

1,714

487

619

686

466

-518

-1,259

-633

-1,035

0

0

0

Deferred Rent

-

0

0

-

-

-

-

-37

0

0

0

-41

-35

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,651

-6,641

-8,133

-8,981

-9,770

0

0

0

Cash flows from investing activities:
Facility lease exit obligation

-

-

-

-

-

-

-

-104

0

0

0

-174

-168

-161

-154

-148

-143

-138

-132

-126

-120

-114

-108

-104

-99

0

0

0

Net cash used in operating activities

-

-

-16,893

-

-

-

-24,906

-28,480

0

0

0

6,943

107

9,881

7,558

-3,014

264

0

0

0

-

-

-

-

-

-

-

-

Capital expenditures

0

0

0

-

-

-

-

75

0

0

0

-

412

444

323

209

43

0

0

0

-

-

-

-

5

0

0

0

Capital expenditures

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,852

3,055

3,324

4,361

2,502

2,698

10,005

9,754

9,354

0

0

0

Proceeds from maturities of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,026

3,796

4,081

6,888

8,800

0

0

0

-

-

-

-

Net cash used in investing activities

-

-

0

-

-

-

-

-1,081

0

0

0

-236

-412

-214

687

2,271

131

0

0

0

-

-

-

-

-

-

-

-

Payments of convertible notes and warrants issuance costs

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,293

7,617

-980

-4,619

-6,339

0

0

0

Cash flows from financing activities:
Net cash provided by financing activities

-

-

0

-

-

-

-

20,690

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

0

-15,819

-

-

-19,185

-5,207

-8,871

0

0

0

6,871

-141

9,799

48,597

39,579

40,717

35,565

-2,115

173

5,266

1,054

-4,673

-638

-3,147

0

0

0

Supplemental disclosure of non-cash activities:
Deferred issuance costs for planned convertible notes and warrants in accrued expenses

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cumulative effect of adoption of new accounting standards

-

-

-

6,046

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued in payment of officer bonus

-

-

-

444

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non cash reduction in other assets from extinguishment of debt and assignment of royalty interests

-

-

-

-

-

-

-

-

-

-

-

-

-237

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non cash reduction in note payable from extinguishment of debt and assignment of royalty interests

-

-

-

-

-

-

-

-

-

-

-

-

9,101

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-